NDT Pharmaceuticals Completes Acquisition of Good Salt(TM) Life, LLC
NDT Pharmaceuticals (OTC:NDTP) has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based biosafety and infection control innovator, on September 5, 2025. Good Salt Life specializes in infection control ecosystems with proprietary hardware and EPA-approved chemistries, operating across 11 countries and 8 industries.
The acquired company serves major clients including Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL. Good Salt Life's portfolio encompasses consumer pet care, home care, cosmetics, antimicrobial chemistry, and chemical delivery technology. The integration aims to create cleaner, safer, and healthier solutions while focusing on sustainability and innovation.
NDT Pharmaceuticals (OTC:NDTP) ha completato l'acquisizione di Good Salt Life, LLC, azienda di Athens, Georgia specializzata in biosicurezza e controllo delle infezioni, il 5 settembre 2025. Good Salt Life si concentra su ecosistemi per il controllo delle infezioni con hardware proprietario e formulazioni approvate dalla EPA, operando in 11 paesi e 8 settori.
L'azienda acquisita serve clienti di rilievo come Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott e la NFL. Il portafoglio di Good Salt Life include prodotti per la cura degli animali domestici, la pulizia domestica, cosmetici, chimica antimicrobica e tecnologie di veicolazione chimica. L'integrazione punta a sviluppare soluzioni più pulite, sicure e salutari, con un focus su sostenibilità e innovazione.
NDT Pharmaceuticals (OTC:NDTP) completó la adquisición de Good Salt Life, LLC, empresa con sede en Athens, Georgia especializada en biosseguridad y control de infecciones, el 5 de septiembre de 2025. Good Salt Life se dedica a ecosistemas de control de infecciones con hardware propio y formulaciones aprobadas por la EPA, operando en 11 países y 8 industrias.
La empresa adquirida atiende a clientes importantes como Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott y la NFL. El portafolio de Good Salt Life abarca cuidado de mascotas, limpieza del hogar, cosméticos, química antimicrobiana y tecnología de entrega química. La integración busca crear soluciones más limpias, seguras y saludables, con un enfoque en sostenibilidad e innovación.
NDT Pharmaceuticals (OTC:NDTP)는 2025년 9월 5일 조지아주 애서즈(Athens)에 본사를 둔 생물안전 및 감염관리 혁신기업 Good Salt Life, LLC 인수를 완료했습니다. Good Salt Life는 독점 하드웨어와 EPA 승인 화학물질을 갖춘 감염관리 생태계를 전문으로 하며, 11개국 8개 산업에서 활동하고 있습니다.
인수된 회사는 Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, NFL 등 주요 고객을 보유하고 있습니다. Good Salt Life의 포트폴리오에는 반려동물용 케어, 가정용 세정, 화장품, 항균 화학물질 및 화학물질 전달 기술이 포함되어 있습니다. 통합을 통해 지속가능성과 혁신에 중점을 두고 더 깨끗하고 안전하며 건강한 솔루션을 창출하는 것을 목표로 합니다.
NDT Pharmaceuticals (OTC:NDTP) a finalisé l'acquisition de Good Salt Life, LLC, société basée à Athens, Géorgie et spécialisée dans la biosécurité et le contrôle des infections, le 5 septembre 2025. Good Salt Life conçoit des écosystèmes de contrôle des infections avec du matériel propriétaire et des formulations approuvées par l'EPA, opérant dans 11 pays et 8 secteurs.
La société acquise dessert des clients majeurs tels que Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott et la NFL. Le portefeuille de Good Salt Life comprend des soins pour animaux de compagnie, des produits d'entretien ménager, des cosmétiques, de la chimie antimicrobienne et des technologies de diffusion chimique. L'intégration vise à créer des solutions plus propres, plus sûres et plus saines, en mettant l'accent sur la durabilité et l'innovation.
NDT Pharmaceuticals (OTC:NDTP) hat am 5. September 2025 die Übernahme von Good Salt Life, LLC, einem auf Biosicherheit und Infektionskontrolle spezialisierten Unternehmen aus Athens, Georgia, abgeschlossen. Good Salt Life entwickelt Infektionskontroll-Ökosysteme mit proprietärer Hardware und von der EPA zugelassenen Chemikalien und ist in 11 Ländern und 8 Branchen tätig.
Das erworbene Unternehmen betreut namhafte Kunden wie Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott und die NFL. Das Portfolio von Good Salt Life umfasst Produkte für Haustierpflege, Haushaltsreinigung, Kosmetik, antimikrobielle Chemie und Chemikalienbereitstellungstechnologie. Die Integration zielt darauf ab, sauberere, sicherere und gesündere Lösungen zu schaffen, mit Schwerpunkt auf Nachhaltigkeit und Innovation.
- Expansion into multiple high-value sectors including healthcare, travel, and sports industries
- Access to established relationships with major corporate clients
- Geographic expansion across 11 countries
- Diversification into multiple product categories including pet care, home care, and cosmetics
- Integration of EPA-approved proprietary technologies and delivery systems
- Financial terms of the acquisition not disclosed
- Integration costs and timeline uncertainties
- Potential operational challenges in managing diverse product portfolio
ATHENS, GA / ACCESS Newswire / September 9, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP) ("NDTP" or the "Company") today announced that it has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based innovator in biosafety and infection control. The transaction closed on Friday, September 5, 2025.
Good Salt Life, a wholly owned subsidiary of NDTP, is a vertically integrated biosafety company that designs, manufactures, and deploys infection control ecosystems combining proprietary hardware, EPA-approved chemistries, and data-driven disinfection protocols. Its solutions serve both animal and human environments across 11 countries and 8 industries, with customers ranging from food producers and hospitals to cruise lines and major sports organizations.
Good Salt Life's brand ecosystem spans consumer pet care, home care, cosmetics, antimicrobial chemistry, and cutting edge chemical delivery technology, including products trusted by leading institutions such as Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL.
"This acquisition marks a transformative moment for NDTP," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "Good Salt Life's mission of combining sustainability, innovation, and wellness aligns perfectly with our vision for growth. Together, we are building a company that is not only committed to shareholder value but also to creating cleaner, safer, and healthier solutions for everyday life."
Additional details on the transaction and integration plans will be shared in the coming weeks.
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, LLC
Good Salt Life, LLC is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life, LLC continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
ir@goodsaltlife.com
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire